- Thu Feb 22, 2024 3:51 pm
#137210
During the segment, Cuomo introduced the topic by highlighting a groundbreaking study by the Global Vaccine Data Network (GVDN), which analyzed the safety of COVID-19 vaccines in a pool of 99 million vaccinated individuals across several countries, including Denmark, New Zealand, Argentina, Canada, Finland, Australia, and Scotland.
Here’s what the study found about how certain health issues showed up after people got their COVID-19 vaccines:
Neurological Conditions:
After getting the first dose of the Oxford/AstraZeneca vaccine, there was a noticeable increase in Guillain-Barré syndrome (GBS), where the body’s immune system attacks its nerves.
Acute disseminated encephalomyelitis (ADEM), a rare brain and spinal cord inflammation, also popped up more than expected after the first Moderna vaccine dose.
Other neurological issues like transverse myelitis (spinal cord inflammation), Bell’s palsy (facial paralysis), and seizures also occurred more than usual after some doses of these vaccines.
Blood Clot and Platelet Conditions:
The Oxford/AstraZeneca vaccine first dose was linked to more cases of cerebral venous sinus thrombosis (CVST), a type of blood clot in the brain, than expected.
There were also more instances of low platelet counts and pulmonary embolism (blood clots in the lungs) after some doses of Oxford/AstraZeneca, Pfizer, and Moderna vaccines.
Some vaccines also led to an increase in splanchnic vein thrombosis (SVT), another type of blood clot, after certain doses, but these findings didn’t signal a major safety concern according to the study’s criteria.
Heart Conditions:
Survival Food Is Surging With an Unexpected Twist: Prepper Beef Company Founder
Cases of myocarditis (heart inflammation) were significantly higher than expected after the first, second, and third doses of mRNA vaccines (like Pfizer and Moderna).
Pericarditis (inflammation of the heart’s outer layer) cases also exceeded expectations after some doses of the Moderna vaccine and after the third dose of the Oxford/AstraZeneca vaccine.
These heart-related findings were considered important safety signals that need attention.
Here’s what the study found about how certain health issues showed up after people got their COVID-19 vaccines:
Neurological Conditions:
After getting the first dose of the Oxford/AstraZeneca vaccine, there was a noticeable increase in Guillain-Barré syndrome (GBS), where the body’s immune system attacks its nerves.
Acute disseminated encephalomyelitis (ADEM), a rare brain and spinal cord inflammation, also popped up more than expected after the first Moderna vaccine dose.
Other neurological issues like transverse myelitis (spinal cord inflammation), Bell’s palsy (facial paralysis), and seizures also occurred more than usual after some doses of these vaccines.
Blood Clot and Platelet Conditions:
The Oxford/AstraZeneca vaccine first dose was linked to more cases of cerebral venous sinus thrombosis (CVST), a type of blood clot in the brain, than expected.
There were also more instances of low platelet counts and pulmonary embolism (blood clots in the lungs) after some doses of Oxford/AstraZeneca, Pfizer, and Moderna vaccines.
Some vaccines also led to an increase in splanchnic vein thrombosis (SVT), another type of blood clot, after certain doses, but these findings didn’t signal a major safety concern according to the study’s criteria.
Heart Conditions:
Survival Food Is Surging With an Unexpected Twist: Prepper Beef Company Founder
Cases of myocarditis (heart inflammation) were significantly higher than expected after the first, second, and third doses of mRNA vaccines (like Pfizer and Moderna).
Pericarditis (inflammation of the heart’s outer layer) cases also exceeded expectations after some doses of the Moderna vaccine and after the third dose of the Oxford/AstraZeneca vaccine.
These heart-related findings were considered important safety signals that need attention.
- By Clownkicker